(1 - 12 von 12
)
AMYT Share News - London South East
www.lse.co.uk
... discussions with the respective health authorities to progress lomitapide as a potential treatment for FCS," said chief medical officer Dr Mark Sumeray. › news › AM...
Amryt Pharma 'delighted' to kick off Episalvan trial
www.centralcharts.com
Mark Sumeray, chief medical officer for Amryt Pharma PLC (LON:AMYT) tells Proactive's Andrew Scott they're delighted to have enrolled their ...
sortiert nach Relevanz / Datum